Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients

Kemi

• Pemetrexed 100%
• Methotrexate 31%
• Elimination Half-Life 27%
• Plasma 15%
• Pemetrexed(2-) 14%
• Pharmacokinetics 14%
• Clearance 13%
• Antifolate 9%
• Vd 8%
• Area Under the Curve 8%
• Cytotoxic Agent 7%
• Plasma Concentration 7%
• Volume 7%
• Drug 6%
• Perchloric Acid 6%
• Reaction Half Life 5%
• Sample Preparation 5%
• Sampling 5%
• High-Pressure Liquid Chromatography 4%
• Platinum 4%
• Molecular Structure 4%
• Protein 2%
• Time 2%

Medicin og biovidenskab

• Pemetrexed 73%
• Non-Small Cell Lung Carcinoma 50%
• Methotrexate 21%
• Half-Life 19%
• Pleura 19%
• Pharmacokinetics 12%
• Perchloric Acid 8%
• Folic Acid Antagonists 7%
• Reverse-Phase Chromatography 7%
• Pharmaceutical Preparations 6%
• Malignant Mesothelioma 6%
• Molecular Structure 6%
• Body Fluids 6%
• Kidney 5%
• Platinum 5%
• Protein Binding 5%
• Blood Proteins 4%
• Salts 4%
• Drainage 4%
• High Pressure Liquid Chromatography 4%
• Area Under Curve 4%
• Infections 2%
• Proteins 2%
• Therapeutics 1%
• Neoplasms 1%